Non-clinical Due Diligence & Data Review
The Peritus Team has the breadth and depth of experience and expertise to support therapeutic and medical devices commercialisation. We have worked with several investment institutions providing expert advice on non-clinical data, reviews, pharmacology and mechanism of action, toxicology and setting appropriate development milestones.
The commercialisaton pathway for both medical technologies and therapeutics can be complex to negotiate, often requiring an expert interpretation of the data and regulatory requirements. Peritus involvement has included:
Due diligence of non-clinical aspects or part of in-house evaluation team
Provision of technical opinion on development and regulatory strategy
Potential licensing deal evaluation
Technical opinion on non-clinical, pharmacology, CMC and regulatory for investment purposes
Identification of potential risks and/or mitigation tactics
Independent deep-dive market research on technology MoA and KOL opinion
Please contact us for support and questions in any non-clinical safety toxicology and CMC related to products and medical devices.